Osteoblastic Responses to TGF-β during Bone Remodeling
- 1 July 1998
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 9 (7) , 1903-1918
- https://doi.org/10.1091/mbc.9.7.1903
Abstract
Bone remodeling depends on the spatial and temporal coupling of bone formation by osteoblasts and bone resorption by osteoclasts; however, the molecular basis of these inductive interactions is unknown. We have previously shown that osteoblastic overexpression of TGF-beta2 in transgenic mice deregulates bone remodeling and leads to an age-dependent loss of bone mass that resembles high-turnover osteoporosis in humans. This phenotype implicates TGF-beta2 as a physiological regulator of bone remodeling and raises the question of how this single secreted factor regulates the functions of osteoblasts and osteoclasts and coordinates their opposing activities in vivo. To gain insight into the physiological role of TGF-beta in bone remodeling, we have now characterized the responses of osteoblasts to TGF-beta in these transgenic mice. We took advantage of the ability of alendronate to specifically inhibit bone resorption, the lack of osteoclast activity in c-fos-/- mice, and a new transgenic mouse line that expresses a dominant-negative form of the type II TGF-beta receptor in osteoblasts. Our results show that TGF-beta directly increases the steady-state rate of osteoblastic differentiation from osteoprogenitor cell to terminally differentiated osteocyte and thereby increases the final density of osteocytes embedded within bone matrix. Mice overexpressing TGF-beta2 also have increased rates of bone matrix formation; however, this activity does not result from a direct effect of TGF-beta on osteoblasts, but is more likely a homeostatic response to the increase in bone resorption caused by TGF-beta. Lastly, we find that osteoclastic activity contributes to the TGF-beta-induced increase in osteoblast differentiation at sites of bone resorption. These results suggest that TGF-beta is a physiological regulator of osteoblast differentiation and acts as a central component of the coupling of bone formation to resorption during bone remodeling.Keywords
This publication has 40 references indexed in Scilit:
- TGF-β receptor signalingBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
- Osteocyte density changes in aging and osteoporosisBone, 1996
- Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.The Journal of cell biology, 1996
- Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfectaJournal of Bone and Mineral Research, 1995
- Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1?34) on rat boneEMC - Cardiologie-Angéiologie, 1995
- Activation of the bone-derived latent TGF beta complex by isolated osteoclastsBiochemical and Biophysical Research Communications, 1989
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Light and electron microscopic demonstration of osteocalcin antigenicity in embryonic and adult rat boneBone, 1986
- Immunolocalization of γ-Carboxyglutamic Acid Containing Proteins in Developing Rat BonesCollagen and Related Research, 1985
- Quantitative histology of osteocyte lacunae in normal human cortical boneCalcified Tissue International, 1976